Skip to main content
SpringerLink
Log in

Drug therapy for spasticity associated with cerebral palsy

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Albright AL. Spastic cerebral palsy: approaches to drug treatment. CNS Drugs 1995 Jul; 4(1): 17–27

    Article  Google Scholar 

  2. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995 Feb; 95(2): 263–9

    PubMed  CAS  Google Scholar 

  3. McKinlay I, Hyde E, Gordon N. Baclofen: a team approach to drug evaluation of spasticity in childhood. Scottish Med J 1980; 25 Suppl.: S26–8

    Google Scholar 

  4. Dahlin M, Knutsson E, Nergardh A. Treatment of spasticity in children with low dose benzodiazepine. J Neurol Sci 1993; 117: 54–60

    Article  PubMed  CAS  Google Scholar 

  5. 1995 Physicians GenRx. St. Louis, Missouri: Mosby-Year Book, Inc., 1995: II-551-3

  6. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991 Mar 20; 265(11): 1418–22

    Article  PubMed  CAS  Google Scholar 

  7. Albright AL, Barron WB, Fasick P, et al. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993 Nov 24; 270(20): 2475–7

    Article  PubMed  CAS  Google Scholar 

  8. Botulinum toxin: an important advance in regional involuntary movement disorders. Drug Ther Perspect 1995 Mar 6; 5(4): 5–8

    Article  Google Scholar 

  9. Calderon-Gonzalez R, Calderon-Sepulveda R, Rincon-Reyes M, et al. Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 1994; 10(4): 284–8

    Article  PubMed  CAS  Google Scholar 

  10. Neville B. Botulinum toxin in the cerebral palsies: grounds for cautious optimism. BMJ 1994 Dec 10; 309: 1526–7

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drug therapy for spasticity associated with cerebral palsy. Drugs Ther. Perspect 7, 8–10 (1996). https://doi.org/10.2165/00042310-199607030-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607030-00003

Search

Navigation